Prosecution Insights
Prosecution Insights
11 pending office actions • 1 client • 11 examiners • 5 art units • 0 of 11 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (18%) |
| §103 only | 1 (9%) |
| §112 only | 2 (18%) |
| Double-patenting only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STUART, CAREY ALEXANDER MC | 1 | 58.3% | +41.6% |
| HILL, MYRON G | 1 | 66.3% | +20.1% |
| GILL, RACHEL B | 1 | 65.5% | +27.9% |
| VU, QUYNH-NHU HOANG | 1 | 68.3% | +27.5% |
| ALAM, DANYAL HASSAN | 1 | 66.7% | +0.0% |
| PARKIN, JEFFREY S | 1 | 63.7% | +21.2% |
| HENZE, DAVID V | 1 | 70.2% | +23.8% |
| FOLEY, SHANON A | 1 | 73.2% | +18.1% |
| RODRIGUEZ, CRIS LOIREN | 1 | 23.6% | +10.2% |
| GEDEON, BRIAN T | 1 | 87.1% | +6.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17855349 | Side-Port Injection Devices For Use With Electroporation, and Related Systems and Methods | RODRIGUEZ, CRIS LOIREN | 5d overdue |
| 18493133 | LASSA VIRUS VACCINE AND USES THEREOF | GILL, RACHEL B | 34d |
| 18493936 | Methods of Treatment of High-Grade Squamous Intraepithelial Lesion (HSIL) | HILL, MYRON G | — |
| 18300588 | Methods Of Treatment Of High Grade Squamous Intraepithelial Lesion (HSIL) | ALAM, DANYAL HASSAN | — |
| 18174298 | Handheld Electroporation Devices, And Related Systems And Methods | HENZE, DAVID V | — |
| 17688429 | ELECTROPORATION DEVICE HAVING A BATTERY PACK WITH POWER SWITCH | GEDEON, BRIAN T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18339387 | INTRADERMAL INJECTION DEVICE | VU, QUYNH-NHU HOANG | 16d overdue |
| 17855349 | Side-Port Injection Devices For Use With Electroporation, and Related Systems and Methods | RODRIGUEZ, CRIS LOIREN | 5d overdue |
| 18493133 | LASSA VIRUS VACCINE AND USES THEREOF | GILL, RACHEL B | 34d |
| 18593320 | METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) | STUART, CAREY ALEXANDER MC | — |
| 18493936 | Methods of Treatment of High-Grade Squamous Intraepithelial Lesion (HSIL) | HILL, MYRON G | — |
| 18300973 | Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use | PARKIN, JEFFREY S | — |
| 18174298 | Handheld Electroporation Devices, And Related Systems And Methods | HENZE, DAVID V | — |
| 18048776 | COMPOSITIONS AND METHODS FOR TREATING ANAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) | FOLEY, SHANON A | — |
| Client (Assignee) | Pending OAs |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | 11 |
| Art Unit | Apps |
|---|---|
| 1671 | 6 |
| 3783 | 2 |
| 1672 | 1 |
| 2859 | 1 |
| 3796 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18593320 | METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) | Inovio Pharmaceuticals, Inc. | STUART, CAREY ALEXANDER MC | 1671 | §102§103§112DP | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18493936 | Methods of Treatment of High-Grade Squamous Intraepithelial Lesion (HSIL) | Inovio Pharmaceuticals, Inc. | HILL, MYRON G | 1671 | §101§103 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18493133 | LASSA VIRUS VACCINE AND USES THEREOF | Inovio Pharmaceuticals, Inc. | GILL, RACHEL B | 1671 | §102§103§112Other | Non-Final OA | 34d | Pending | Oct 24, 2023 |
| 18339387 | INTRADERMAL INJECTION DEVICE | Inovio Pharmaceuticals, Inc. | VU, QUYNH-NHU HOANG | 3783 | §112Other | Final Rejection | 16d overdue | Pending | Jun 22, 2023 |
| 18300588 | Methods Of Treatment Of High Grade Squamous Intraepithelial Lesion (HSIL) | Inovio Pharmaceuticals, Inc. | ALAM, DANYAL HASSAN | 1672 | §101§103 | Final Rejection | — | Pending | Apr 14, 2023 |
| 18300973 | Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use | Inovio Pharmaceuticals, Inc. | PARKIN, JEFFREY S | 1671 | §112 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18174298 | Handheld Electroporation Devices, And Related Systems And Methods | Inovio Pharmaceuticals, Inc. | HENZE, DAVID V | 2859 | §102§103 | Non-Final OA | — | Pending | Feb 24, 2023 |
| 18048776 | COMPOSITIONS AND METHODS FOR TREATING ANAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) | Inovio Pharmaceuticals, Inc. | FOLEY, SHANON A | 1671 | DP | Final Rejection | — | Pending | Oct 21, 2022 |
| 17855349 | Side-Port Injection Devices For Use With Electroporation, and Related Systems and Methods | Inovio Pharmaceuticals, Inc. | RODRIGUEZ, CRIS LOIREN | 3783 | §103§112 | Final Rejection | 5d overdue | Pending | Jun 30, 2022 |
| 17688429 | ELECTROPORATION DEVICE HAVING A BATTERY PACK WITH POWER SWITCH | Inovio Pharmaceuticals, Inc. | GEDEON, BRIAN T | 3796 | §102§103 | Final Rejection | — | Pending | Mar 07, 2022 |
| 17221032 | COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA | Inovio Pharmaceuticals, Inc. | ZOU, NIANXIANG | 1671 | §103 | Final Rejection | — | Pending | Apr 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial